Strategies to optimize drug half-life in lead candidate identification
- 11 January 2019
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Drug Discovery
- Vol. 14 (3), 221-230
- https://doi.org/10.1080/17460441.2019.1569625
Abstract
Introduction: The PK optimization of drug candidates is one of the most resource-intensive tasks in pharmaceutical research and development. With the increasing availability of in silico, in vitro and mechanistic in vivo ADME models, drug discovery scientists have progressively learned to recognize common SAR patterns and engineer data-driven strategies to accelerate the resolution of ADME issues in lead optimization. Many of these strategies gravitate toward the concept of drug-likeness, which defines a number of optimal holistic physicochemical parameters (such as lipophilicity) that idealized oral drugs possess. Areas covered: Herein, the authors discuss the interplay of lipophilicity with in vitro and in vivo ADME data in order to refine existing thought around drug half-life optimization. Strategies to prolong the half-life of oral drugs via formulation are beyond the scope of this review. Expert opinion: Optimizing active properties such as potency, selectivity, and intrinsic metabolic clearance is an unambiguously beneficial strategy for small molecules within or beyond the Lipinski rule of five chemical space. The data that we present in this work suggests that emphasis should be primarily placed on optimizing active properties such as potency, selectivity, and metabolic stability.Keywords
Funding Information
- Genentech Inc
This publication has 44 references indexed in Scilit:
- Software aided approaches to structure-based metabolite identification in drug discovery and developmentDrug Discovery Today: Technologies, 2013
- Exposition and reactivity optimization to predict sites of metabolism in chemicalsDrug Discovery Today: Technologies, 2013
- Strategies to improve in vivo toxicology outcomes for basic candidate drug moleculesBioorganic & Medicinal Chemistry Letters, 2011
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- BDDCS Applied to Over 900 DrugsThe AAPS Journal, 2011
- Using the Golden Triangle to optimize clearance and oral absorptionBioorganic & Medicinal Chemistry Letters, 2009
- The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage FormsPharmaceutical Research, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- CYP2C9 Structure−Metabolism Relationships: Substrates, Inhibitors, and MetabolitesJournal of Medicinal Chemistry, 2007
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977